Publications

Hogan Lovells Publications

FIG Bulletin, 16 August 2019

We are delighted to send you our latest e-newsletter, setting out recent regulatory developments of interest to financial institutions.

Hogan Lovells Publications

A bit more Sunshine: CMS proposes collecting additional information on manufacturer payments under the Open Payments program

Device and drug manufacturers got a small surprise in the annual Physician Fee Schedule proposed rule (at 40,713-16) issued late in July by the Centers for Medicare & Medicaid Services...

Hogan Lovells Publications

Proposed additions of chemical families to Schedule 1 of Chemical Weapons Convention and BIS requests for comments from chemical, biotechnology and pharmaceutical companies

On 14 August 2019 the U.S. Department of Commerce published a proposed change to the list of "Schedule 1" chemicals in the "Annex on Chemicals" to the Chemical Weapons Convention (CWC).

Hogan Lovells Publications

Webinar summary: Artificial Intelligence – Getting to grips with basics and legal implications

Jason Lohr (San Francisco) held the first in a series of internal webinars on the basics and legal implications of artificial intelligence (AI) and machine learning, highlighting their...

Hogan Lovells Publications

Workplace pensions in Germany: what you need to know

In Germany, paying contributions to the statutory (state) social security pension is compulsory for most employees and their employers.

Hogan Lovells Publications

Back to basics: what to do when you receive a break notice

In the current climate, all types of occupiers including occupiers of retail, office and warehouse space, will be considering their leasing requirements and looking to rationalise their...

Hogan Lovells Publications

U.S.-China trade war escalates with new round of Section 301 tariffs and currency manipulation designation

Following on the heels of U.S. trade negotiators’ return from China, on 1 August, President Trump abruptly announced via Twitter an “additional Tariff of 10 percent on the...

Hogan Lovells Publications

New draft guidance on MR compatibility for medical devices

The U.S. Food and Drug Administration (FDA) has published a new draft guidance titled "Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment."

;
Loading data